파킨슨병 SwallowFIT 연구
"SwallowFit," 파킨슨병에 영향을 받는 미국 군인, 참전용사 및 가족들을 위해 설계된 운동 프로그램 및 무작위 임상 시험.
The goal of this clinical trial is to learn if a proactive swallow exercise will help to improve swallow fitness in patients with Parkinson's disease.
The aim of the study is to assess how effective this exercise is and to measure the change in swallowing fitness from the beginning to the end of the study.
Patients who are given the exercise training will be compared to participants who are treated using the usual standard treatment.
Patients will have 6 weeks of twice-weekly SwallowFIT training. Each session will be an hour long.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
SwallowFIT: Subjects will receive 6-weeks of twice weekly SwallowFIT intervention per protocol (1-hour session each visit) from the BAMC speech language Pathologist (study SLP) at BAMC. Completion of the program will include 12 visits. The program is designed from a previous successful pilot trial. It begins with provision of general education on swallowing and swallowing change from the Parkinson's Foundation and Michael J Fox association websites.
Following this the program trains a modified effortful swallow technique at its onset using sEMG to guide the development of better swallow movement form, effort and performance. Once swallowing form is established, the program uses a hierarchy of swallowing tasks involving swallowing food/fluid materials at different complexity levels (swallow specificity) to stimulate and train progressive resistance and leverage variability of coordinated speeded actions.
Clinical Monitoring Only (CMO): This intervention mirrors the experimental intervention in all aspects, but the treatment type applied. CMO intervention reflects current swallow management practice for PD, where physicians monitor clinical function in swallowing and other related symptomology, referring for swallowing treatment only once an obvious issue has been identified.
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Giselle Carnaby, PhD, MPH
- 전화번호: 210-450-7130
- 이메일: carnaby@uthscsa.edu
연구 장소
-
-
Texas
-
San Antonio, Texas, 미국, 78234-6200
- Brooke Army Medical Center (BAMC)
-
연락하다:
- Giselle Carnaby, PhD, MPH
- 전화번호: 210-450-7130
- 이메일: carnaby@uthscsa.edu
-
연락하다:
- Alexis Nelson
- 전화번호: 210-916-2203.
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Adult S-VWP between >35-90 years of age
- Diagnosis of Idiopathic Parkinson's Disease [IDP] (either or suspected, tremor-predominant or rigid predominant)
- Disability level of Hoehn & Yahr stages II-III as indicated in their most recent neurological evaluation
- Swallowing concern, confirmed by Modified Unified Parkinson Disease Rating Scale [MDS-UPDRS]-
- ADL swallowing item >0, or Mann Assessment of Swallowing scale [MASA] score ≤185.
- Able to consume oral nutrition [Functional Oral Intake Score ≤ 6]
- Ambulatory
- No change of medication for at least 4 weeks before study inclusion
Exclusion Criteria:
- Classified as Hoehn and Yahr stages IV
- Unable to follow 2 step commands
- History of other neurological disease potentially causing dysphagia
- Dementia (MMSE<20; Montreal cognitive assessment (MoCA) ≤ 20)
- Severe depression (BDI>19)
- Severe dyskinesia of head and neck (resulting in problems with MBSS recording)
- Severe documented Gastrointestinal disease
- History of Gastro-esophageal surgery
- History of Head or neck cancer with swallowing impairment or surgical intervention
- History of breathing disorders or diseases (e.g., Asthma, chronic obstructive pulmonary disease (COPD) requiring assistive breathing support.
- Untreated hypertension
- Heart disease requiring restricted activity and medical intervention
- Speech therapy intervention for swallowing within the past three months
- Women who are pregnant, nursing, or who plan to become pregnant during the study
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: SwallowFit Intervention
Subjects randomized to intervention will receive 6-weeks of twice weekly SwallowFIT per protocol (1-hour session each day). The program begins with provision of general education on swallowing and swallowing change from the Parkinson's Foundation and Michael J Fox association websites. Following this the program trains a modified effortful swallow technique at its onset using surface electromyographic (sEMG) biofeedback to guide the development of better swallow movement form, effort and performance. From there it applies a hierarchy of swallowing exercises/tasks involving swallowing food/fluid materials at different complexity levels (swallow specificity) to stimulate and train progressive resistance and leverage variability of coordinated speeded actions. |
The SwallowFIT protocol follows an increasing task difficulty (levels on the hierarchy) and motor learning strategy. Progression on the hierarchy is guided and monitored by the occurrence of inefficiency markers in swallow wing (e.g. excessive lingual pumping, swallow hesitation, throat clearing etc.) confirmed from the baseline clinical and video fluoroscopic evaluations.
다른 이름들:
|
|
간섭 없음: Clinical Monitoring Only (CMO)
CMO intervention reflects current swallow management practice for PD, where physicians monitor clinical function in swallowing and other related symptomology, referring for swallowing treatment only if an obvious issue has been identified. Subjects randomized to CMO will also receive general education on swallowing and swallow changes from the Parkinson's Foundation and Michael J Fox association websites. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Mann Assessment of Swallowing Ability (MASA)
기간: Baseline to 6 months
|
The MASA score is measured using a 5-point to 10-point rating scale. The total possible score of the MASA is 200 points, and the cutoff value is 177 points. The results of the MASA are interpreted as no abnormality (≥178), mild dysphagia (168-177), moderate dysphagia (139-167), and severe dysphagia (≤138). |
Baseline to 6 months
|
|
Modified Unified Parkinson Disease Rating Scale (MDS-UPDRS)
기간: Baseline to 6 months
|
The MDS-UPDRS uses a 0-4 scoring system, with higher scores indicating more severe symptoms. Parts I-III are scored on a 0-4 scale, while Part IV uses "yes" and "no" ratings. The total score range is 0-260, with 0 representing no disability and 260 representing total disability. |
Baseline to 6 months
|
|
Modified Hoehn and Yahr (HY) Scale
기간: Baseline to 6 months
|
The Hoehn and Yahr (H&Y) scale is a grading system used to assess the progression and severity of motor symptoms in Parkinson's disease (PD). It ranges from Stage 0 (no signs of disease) to Stage 5 (severe disability, wheelchair or bed bound). Stages 1, 1.5, 2, and 2.5 are considered early stages, while stages 3, 4, and 5 represent later, more advanced stages. |
Baseline to 6 months
|
|
Montreal Cognitive Assessment (MoCA)
기간: Baseline to 6 months
|
The Montreal Cognitive Assessment (MoCA) is a cognitive screening tool with a maximum score of 30 points, with a score of 26 or higher generally indicating normal cognitive function. Scores between 18 and 25 may suggest mild cognitive impairment (MCI), while scores below 18 may indicate moderate to severe impairment. |
Baseline to 6 months
|
|
PD Quality of Life Scale (PDQ-39)
기간: Baseline to 6 months
|
The PDQ-39 is a questionnaire used to assess the impact of Parkinson's disease on quality of life. It consists of 39 questions, each rated on a 5-point scale from 0 (never) to 4 (always). Scores for the 39 questions are added to obtain a total score. The scores for the 8 subscales (mobility, activities of daily living, emotional well-being, stigma, social support, cognition, communication, and physical discomfort) are obtained by summing the scores for the relevant questions within each subscale. The total score and subscale scores range from 0 to 100, with higher scores indicating a greater impact of Parkinson's disease on quality of life. |
Baseline to 6 months
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Modified Barium Swallowing Impairment Profile, overall impression score (MBSImp OI score)
기간: Baseline to 6 months
|
In the context of the Modified Barium Swallow Impairment Profile (MBSImP), Overall Impression (OI) scoring is the most common method used to assess swallowing physiology. It involves assigning a score to each of the 17 physiological components based on the most severe impairment observed across different swallowing tasks. These scores range from 0 to 4 depending on the component, and total scores range from 0-68 with higher scores indicating greater impairment. |
Baseline to 6 months
|
|
Spontaneous Swallowing Frequency (SSF)
기간: Baseline to 6 months
|
Spontaneous swallowing frequency (SSF) scoring refers to counting the number of times a person swallows without any specific prompting or external stimuli. It's a method used to assess swallowing function, particularly in conditions like dysphagia (difficulty swallowing), and can be a tool for screening and evaluating swallowing problems. A 5-10 minute sampling window is often used to calculate SSF. Healthy Swallowing: In healthy individuals, spontaneous swallowing typically occurs at a rate of 1-2 swallows per minute. Dysphagia: Patients with dysphagia often have a reduced SSF compared to healthy individuals. Thresholds: Some studies have suggested a threshold of 0.40 swallows per minute as a potential indicator of significant dysphagia. |
Baseline to 6 months
|
|
Penetration Aspiration Scale (PAS)
기간: Baseline to 6 months
|
The Penetration-Aspiration Scale (PAS) is an 8-point scale used to assess the depth and response to airway invasion during swallowing. It helps clinicians and researchers understand the severity of swallowing dysfunction by categorizing the location of the bolus within the airway and whether it's expelled or not. The scale is used in videofluoroscopic swallowing studies (VFSS) to quantify swallowing event. A score of 1 would indicate no material entered the airway while a score of 8 would indicate the most amount of material aspirated during swallowing. |
Baseline to 6 months
|
|
Analysis of Swallowing Physiology: Events, Kinematics and Timing (ASPEKT)
기간: Baseline to 6 months
|
Method of measuring physiologic kinematics and timing for swallowing images retrieved from modified barium swallow (MBSS). It evaluates of 8 key parameters of swallowing taken by frame analysis on open-source NIH, Image J software. Scoring of kinematic swallow movements will be evaluated using the published protocol |
Baseline to 6 months
|
|
Functional Oral Intake Scale (FOIS)
기간: Baseline to 6 months
|
The Functional Oral Intake Scale (FOIS) is a 7-point ordinal scale used to assess a patient's ability to swallow and eat safely and efficiently. Scores range from 1 to 7, with higher scores indicating better swallowing function and a greater ability to participate in oral intake. |
Baseline to 6 months
|
|
Lingual Pressure/movement
기간: Baseline to 6 months
|
The Lingual Pressure Movement Scale, part of the AIMS (Abnormal Involuntary Movement Scale), assesses the severity of tongue movements. It uses a 0-4 scale, where 0 represents no movement, 1 represents minimal movement (may be extreme normal), 2 represents mild movement, 3 represents moderate movement, and 4 represents severe movement. |
Baseline to 6 months
|
|
Sydney Swallowing Questionnaire (SSQ)
기간: Baseline to 6 months
|
The Sydney Swallow Questionnaire (SSQ) is scored by summing the individual scores for each question. It consists of 17 questions, with most questions scored on a visual analog scale (VAS), ranging from 0 to 100 mm. The total possible score is 1700. Higher scores indicate more severe swallowing difficulties. |
Baseline to 6 months
|
|
Protocol Adherence Measure
기간: Baseline to 6 months
|
Percentage attendance measured by number of prescribed exercise sessions completed |
Baseline to 6 months
|
|
Patient Perception of Swallowing (VAS)
기간: Baseline to 6 months
|
In patient perception of swallowing, a Visual Analogue Scale (VAS) is used to assess a patient's subjective experience of swallowing difficulties. Patients mark a point on a line (typically 100 mm) that represents the severity of their swallowing problem, with 0 indicating no trouble and 100 indicating a total inability to swallow. |
Baseline to 6 months
|
|
Patient/Caregiver Acceptability/Satisfaction Scale (PA/SS)
기간: Baseline to 6 months
|
A 5 item scale where each item is scored on a Likert scale from 0-10. Total scores range from 0-50 with a higher score indicating that the SwallowFIT program was more helpful. |
Baseline to 6 months
|
공동 작업자 및 조사자
스폰서
스폰서
협력자
협력자
수사관
수사관
- 수석 연구원: Giselle Carnaby, PhD, MP, The University of Texas Health Science Center at San Antonio
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- STUDY00001444
- FY24 HT942524PRPIIRA (기타 보조금/기금 번호: Department of Defense)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
The study team will report and publish in a peer-reviewed journal (trials journal) the study protocol and proposed analysis, to provide similar information to the national and international scientific community.
Information provision and awareness-raising will take place during project inception and intensify as results become available.
Study results will be published and displayed on the project webpage following completion of the 6 month follow up of all subjects.
IPD 공유 기간
After the study is complete and unblinded, the study team will submit all remaining scientific data to the data repository, and we will update the study status to "completed" in clinical trials.gov. According to the study timeline, all generated scientific data will approximately coincide with the submission of the results to clinicaltrials.gov and will occur no later than by the end of award. Scientific data included in published manuscripts will be available at the time of publication. According to the proposed project timeline, all generated scientific data will approximately coincide with the submission of the results to clinicaltrials.gov at the end of the award, and full data sharing (via repository) will occur no later than six months after completion of the study or acceptance for publication of the main findings from the final dataset.
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
- ICF
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .